Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to Castro Medical Technology's second quarter fiscal 2026 earnings call. This conference call is being recorded for replay purposes. We will be facilitating a question and answer session following some fair remarks from management at this time. All participants are in a listen-only mode. I would now like to turn the call over to Neil Baladkar, Vice President of Investor Relations, for introductory comments. Thank you, Victor. Thank you for joining Testra's second quarter fiscal 2026 earnings call. With me today are Brian Webster, President and Chief Executive Officer, and Vasim Mahbub, Chief Financial Officer. This call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. These statements are based on Kestra's current expectations, forecasts, and assumptions, which are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Actual outcomes and results could differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements due to various factors. Please review Kestra's most recent filings with the SEC, particularly the risk factors described in our Form 10-K, for additional information. Any forward-looking statements provided during this call, including projections of future performance, are based on management's expectations as of today. Keshra undertakes no obligation to update these statements except as required by applicable law. With that, I will now turn the call over to Brian. Thanks, Neil. Good afternoon, everyone, and thank you for joining us on today's conference ...